Pharmacogenetic treatments for drug addiction: alcohol and opiates.
about
Breaking barriers in the genomics and pharmacogenetics of drug addictionImproving temporal efficiency of outpatient buprenorphine induction.Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validityThe World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and responseOPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent.Perceptions of genetic testing and genomic medicine among drug users.Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activityContribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent.Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.Mu-opioid stimulation in rat prefrontal cortex engages hypothalamic orexin/hypocretin-containing neurons, and reveals dissociable roles of nucleus accumbens and hypothalamus in cortically driven feeding.Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.Preclinical evidence of new opioid modulators for the treatment of addiction.Dopaminergic reward system: a short integrative review.Pathways to heroin dependence: time to re-appraise self-medication.Orquestic regulation of neurotransmitters on reward-seeking behavior.Pharmacologically targeting the P2rx4 gene on maintenance and reinstatement of alcohol self-administration in rats.Substance abuse is a disease of the human brain: focus on alcohol.Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.The potential of pharmacogenomics to treat drug addiction.Naltrexone in the treatment of binge eating disorder in a patient with severe alcohol use disorder: a case report.
P2860
Q30417717-76D79DCB-BEE1-4F80-A04B-25C97763389AQ30425074-144B64DF-7EE7-4AC5-B634-D23AC085595DQ30447847-C9BA35FC-6A35-4389-93C6-B5533C51AB25Q33870389-EABFDA4F-213B-46CC-8F02-B813CC6D3450Q33903933-EB99F9B1-2CB4-49BC-83A6-15D846CB0163Q33921223-A9A16C5A-772B-441C-BB07-C0424C149578Q34081859-DEA5CA1D-95CD-44C5-94DD-CB5C325F5DCAQ34410506-45905F1B-C814-409D-9930-0F1647245A0DQ34772602-70971F92-C739-45F2-BF72-3F7AB41210A4Q34982551-71B81478-3308-45C5-AC10-D57BCA38AE8EQ35684822-29D54249-172C-4BBE-8055-B292408DE1ABQ36354160-FCD5B816-F5D9-4641-BFED-300C72502F81Q36441544-C8E9F028-3BD9-478C-BB66-56C74BF63541Q37160674-1EBA9B52-D80F-4963-AD20-4D2E9F5529B0Q37325389-32B48D46-74ED-410F-8FB3-E46A43F0C5FBQ37404222-AD22256A-6CC5-42E4-8461-075E1AF7812DQ37453915-5EA5A216-D746-44C2-88C8-FA78C9DD794BQ37772519-4F032DD2-156C-4AD0-9C54-384AE227EF75Q37798319-92D42C31-C045-485B-8AF8-426B941C21B3Q38052920-04B9BB69-4E57-44B0-8E8E-854FD9D5C872Q38233865-06C6CB2F-2778-4382-A611-25EA7C100753Q42721730-FF852B6D-4DAA-4EE1-BC62-6CAAFD38B441Q42792814-B675C73C-B93D-4176-9855-9A00D8A8A5D4Q51849418-883BA043-1B25-40B5-93C5-C3E923FF0C1BQ52295623-6D0CD71B-CD07-421C-8308-A99871FA1BFEQ52312353-6C15A52A-E09D-49BC-A4C1-EFDE70B3322F
P2860
Pharmacogenetic treatments for drug addiction: alcohol and opiates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenetic treatments for drug addiction: alcohol and opiates.
@en
Pharmacogenetic treatments for drug addiction: alcohol and opiates.
@nl
type
label
Pharmacogenetic treatments for drug addiction: alcohol and opiates.
@en
Pharmacogenetic treatments for drug addiction: alcohol and opiates.
@nl
prefLabel
Pharmacogenetic treatments for drug addiction: alcohol and opiates.
@en
Pharmacogenetic treatments for drug addiction: alcohol and opiates.
@nl
P2860
P1476
Pharmacogenetic treatments for drug addiction: alcohol and opiates
@en
P2093
Therese A Kosten
Thomas R Kosten
P2860
P304
P356
10.1080/00952990802122564
P577
2008-01-01T00:00:00Z